HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inflammation and Adverse Outcomes in Patients With Acute Ischemic Stroke With and Without Chronic Kidney Disease.

AbstractBACKGROUND:
Elevated white blood cell count, fibrinogen levels, and lower levels of albumin signify higher systemic inflammatory response, hypercoagulable state, and poorer nutritional status, respectively. However, a consistent conclusion could not be drawn on whether the association between inflammatory markers and cardiovascular disease was affected by the presence of chronic kidney disease (CKD). We aimed to explore the association between inflammation and adverse outcomes in patients with acute ischemic stroke (AIS), as well as whether this association differs due to the presence of CKD.
METHODS AND RESULTS:
This research was based on the Third China National Stroke Registry. The main adverse outcomes were poor functional outcome, stroke recurrence, and combined vascular event after 1 year. Inflammation was defined as the worst quartile of at least 2 of the aforementioned 3 markers. Finally, 8493 patients with AIS were enrolled in this study. The adjusted odds ratios/hazard ratios and 95% CIs of inflammation were 1.58 (1.34-1.86) for poor functional outcomes, 1.25 (1.06-1.47) for stroke recurrence, and 1.25 (1.06-1.46) for combined vascular event. The association between inflammation and adverse outcomes existed only in patients with AIS without CKD, although the interaction between CKD and inflammation was not statistically significant. (P for interaction >0.05).
CONCLUSIONS:
Inflammation, which was defined as a combination of fibrinogen, white blood cell count, and albumin, was associated with all 1-year adverse outcomes among patients with AIS. Routine assessment of these biomarkers could become a potential part of the clinical evaluation for patients with AIS, especially those without CKD, aiding clinicians in risk stratification and treatment decision-making.
AuthorsXiaoyu Wang, Yuesong Pan, Runhua Zhang, Mengxing Wang, Xia Meng, Zixiao Li, Hao Li, Yilong Wang, Xingquan Zhao, Yongjun Wang, Gaifen Liu
JournalJournal of the American Heart Association (J Am Heart Assoc) Vol. 13 Issue 9 Pg. e033450 (May 07 2024) ISSN: 2047-9980 [Electronic] England
PMID38686855 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study)
Chemical References
  • Biomarkers
  • Fibrinogen
Topics
  • Humans
  • Male
  • Female
  • Ischemic Stroke (blood, epidemiology, diagnosis)
  • Renal Insufficiency, Chronic (complications, epidemiology, blood, diagnosis)
  • Middle Aged
  • Aged
  • China (epidemiology)
  • Inflammation (blood)
  • Registries
  • Biomarkers (blood)
  • Recurrence
  • Risk Factors
  • Risk Assessment
  • Prognosis
  • Fibrinogen (analysis, metabolism)
  • Leukocyte Count

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: